Matches in Wikidata for { <http://www.wikidata.org/entity/Q91675602> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q91675602 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91675602 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91675602 description "scientific article published on 08 October 2019" @default.
- Q91675602 description "wetenschappelijk artikel" @default.
- Q91675602 description "наукова стаття, опублікована 8 жовтня 2019" @default.
- Q91675602 name "Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial" @default.
- Q91675602 name "Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial" @default.
- Q91675602 type Item @default.
- Q91675602 label "Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial" @default.
- Q91675602 label "Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial" @default.
- Q91675602 prefLabel "Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial" @default.
- Q91675602 prefLabel "Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial" @default.
- Q91675602 P1433 Q91675602-993EF155-067C-4D2F-97B8-1CCBC5FD51E0 @default.
- Q91675602 P1476 Q91675602-D35220F8-8256-47E2-AE07-E1DE208FFE4A @default.
- Q91675602 P2093 Q91675602-063159D3-FEF3-4634-8EDA-D0452E99CA9F @default.
- Q91675602 P2093 Q91675602-13A13350-E0AD-4628-B360-03D079D0EAA7 @default.
- Q91675602 P2093 Q91675602-3D3ACC1C-B9FF-4782-A0BD-53665A13EECF @default.
- Q91675602 P2093 Q91675602-503F8264-A755-47E7-AB75-3EFD1CF595A6 @default.
- Q91675602 P2093 Q91675602-672679BE-6191-4AC7-83D2-45A61F6FF6C0 @default.
- Q91675602 P2093 Q91675602-8A6445C1-5688-4B95-9983-4F8505191F09 @default.
- Q91675602 P2093 Q91675602-950EB56C-E56B-4184-80CF-9BBD713773E7 @default.
- Q91675602 P2093 Q91675602-B3B77BB8-79A9-40A8-B874-CD92FB073211 @default.
- Q91675602 P2093 Q91675602-C30D9443-C67C-40D7-B842-5E8C37FDF0B6 @default.
- Q91675602 P2093 Q91675602-DAAA04B6-566E-41F1-922E-5ED5ABDC15DB @default.
- Q91675602 P2093 Q91675602-E2732846-3E20-409F-B3B3-C560076C5B22 @default.
- Q91675602 P2093 Q91675602-E2CD9C47-EA0C-46A5-A7E6-F980196FD93C @default.
- Q91675602 P2093 Q91675602-EA750861-9A27-4A4F-AEB2-F03E203488D4 @default.
- Q91675602 P2093 Q91675602-F147FB26-3E03-4ED4-8C3B-0957B7AB3AAC @default.
- Q91675602 P304 Q91675602-D367E2A1-498A-4752-9E28-727CDDFA1E36 @default.
- Q91675602 P31 Q91675602-FCEDB168-AEED-4AC0-91A2-E9BF06F13BAE @default.
- Q91675602 P356 Q91675602-EBD19E9C-EAF2-4278-B3BB-39C581B8511D @default.
- Q91675602 P433 Q91675602-F5CCD86C-5C80-4677-A4A1-87E2744F5955 @default.
- Q91675602 P478 Q91675602-D7968358-1B9F-485B-9DFE-A5C121A06714 @default.
- Q91675602 P50 Q91675602-33FC1D43-8BDD-403F-84FD-9DF790348658 @default.
- Q91675602 P50 Q91675602-7C02F612-1891-4CFD-9FF5-A89CC653C66A @default.
- Q91675602 P50 Q91675602-935DF6BE-F7A3-4150-B928-D77A0D1209CA @default.
- Q91675602 P50 Q91675602-A2EDC4A4-EBDE-487B-ADAE-36EE238A5E18 @default.
- Q91675602 P50 Q91675602-E5F4716E-2B6D-4C25-AABE-A16E4B23FA6D @default.
- Q91675602 P577 Q91675602-B094D4FD-AFA4-4001-BCAA-164179222F11 @default.
- Q91675602 P698 Q91675602-7711F928-F71C-4A84-ADEE-6F0EF4316EBF @default.
- Q91675602 P932 Q91675602-6E2D357A-0E9E-4040-A224-291B72B0B6B9 @default.
- Q91675602 P356 000503032 @default.
- Q91675602 P698 31799207 @default.
- Q91675602 P1433 Q26842090 @default.
- Q91675602 P1476 "Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial" @default.
- Q91675602 P2093 "Chikara Ogawa" @default.
- Q91675602 P2093 "Etsuro Hatano" @default.
- Q91675602 P2093 "Fumihiko Kanai" @default.
- Q91675602 P2093 "Hiroaki Nagano" @default.
- Q91675602 P2093 "Kazuhide Yamamoto" @default.
- Q91675602 P2093 "Kazuomi Ueshima" @default.
- Q91675602 P2093 "Keisuke Hino" @default.
- Q91675602 P2093 "Sadahisa Ogasawara" @default.
- Q91675602 P2093 "Shouta Iwadou" @default.
- Q91675602 P2093 "Shuntaro Obi" @default.
- Q91675602 P2093 "Takuji Okusaka" @default.
- Q91675602 P2093 "Yasuaki Arai" @default.
- Q91675602 P2093 "Yasutaka Chiba" @default.
- Q91675602 P2093 "Yutaka Sasaki" @default.
- Q91675602 P304 "505-519" @default.
- Q91675602 P31 Q13442814 @default.
- Q91675602 P356 "10.1159/000503032" @default.
- Q91675602 P433 "6" @default.
- Q91675602 P478 "8" @default.
- Q91675602 P50 Q115048156 @default.
- Q91675602 P50 Q40473885 @default.
- Q91675602 P50 Q89534368 @default.
- Q91675602 P50 Q90377862 @default.
- Q91675602 P50 Q90690384 @default.
- Q91675602 P577 "2019-10-08T00:00:00Z" @default.
- Q91675602 P698 "31799207" @default.
- Q91675602 P932 "6883462" @default.